AU2001237633A1 - Method of identifying modulators of presenilin - Google Patents
Method of identifying modulators of presenilinInfo
- Publication number
- AU2001237633A1 AU2001237633A1 AU2001237633A AU3763301A AU2001237633A1 AU 2001237633 A1 AU2001237633 A1 AU 2001237633A1 AU 2001237633 A AU2001237633 A AU 2001237633A AU 3763301 A AU3763301 A AU 3763301A AU 2001237633 A1 AU2001237633 A1 AU 2001237633A1
- Authority
- AU
- Australia
- Prior art keywords
- presenilin
- identifying modulators
- modulators
- identifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0005894.1A GB0005894D0 (en) | 2000-03-10 | 2000-03-10 | Assay |
GB0005894 | 2000-03-10 | ||
PCT/GB2001/001057 WO2001067109A1 (en) | 2000-03-10 | 2001-03-09 | Method of identifying modulators of presenilin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001237633A1 true AU2001237633A1 (en) | 2001-09-17 |
Family
ID=9887438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001237633A Abandoned AU2001237633A1 (en) | 2000-03-10 | 2001-03-09 | Method of identifying modulators of presenilin |
Country Status (5)
Country | Link |
---|---|
US (1) | US20030113811A1 (en) |
EP (1) | EP1259821A1 (en) |
AU (1) | AU2001237633A1 (en) |
GB (1) | GB0005894D0 (en) |
WO (1) | WO2001067109A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2417136A1 (en) * | 2000-09-01 | 2002-03-07 | The Governing Council Of The University Of Toronto | Proteins related to schizophrenia and uses thereof |
GB0024086D0 (en) * | 2000-10-02 | 2000-11-15 | Inpharmatica Ltd | Proteinase |
WO2005074980A1 (en) * | 2004-01-29 | 2005-08-18 | Cellzome Ag | Treatment of neurodegenerative diseases by the use of gpr49 |
US8129334B2 (en) | 2006-03-31 | 2012-03-06 | The Regents Of The University Of California | Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory |
AU2007241056A1 (en) | 2006-03-31 | 2007-11-01 | The Regents Of The University Of California | Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9608657D0 (en) * | 1996-04-26 | 1996-07-03 | Smithkline Beecham Plc | Novel treatment |
WO2000060069A1 (en) * | 1999-04-01 | 2000-10-12 | The Governing Council Of The University Of Toronto | A presenilin associated membrane protein and uses thereof |
-
2000
- 2000-03-10 GB GBGB0005894.1A patent/GB0005894D0/en not_active Ceased
-
2001
- 2001-03-09 EP EP01910050A patent/EP1259821A1/en not_active Withdrawn
- 2001-03-09 WO PCT/GB2001/001057 patent/WO2001067109A1/en not_active Application Discontinuation
- 2001-03-09 US US10/221,254 patent/US20030113811A1/en not_active Abandoned
- 2001-03-09 AU AU2001237633A patent/AU2001237633A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030113811A1 (en) | 2003-06-19 |
EP1259821A1 (en) | 2002-11-27 |
WO2001067109A1 (en) | 2001-09-13 |
GB0005894D0 (en) | 2000-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5338099A (en) | Method of advertising | |
AU2001267740A1 (en) | Separation method | |
AU2001241075A1 (en) | Method of anticipating interaction between proteins | |
AU3091599A (en) | Method of making dimethylnaphtalenes | |
AU2001235725A1 (en) | Multichannel element and method for making same | |
AU2002321549A1 (en) | Method of providing information | |
AU2001273694A1 (en) | Method for changing color | |
AU2000270441A1 (en) | Advertising method | |
AU2002214487A1 (en) | Method for inducing apoptiosis | |
AU2002227036A1 (en) | Method of creating photonic via | |
AU2001237633A1 (en) | Method of identifying modulators of presenilin | |
AU2001237530A1 (en) | Method | |
AU4124101A (en) | Method of making silver-contained candle | |
AU2002216479A1 (en) | Isolation method | |
AU2001241636A1 (en) | Halotherapy method | |
AU2002225169A1 (en) | Method for identifying modulators of bace | |
AU2001289632A1 (en) | Method for addressing terminals | |
AU2002225174A1 (en) | Method of identifying modulators of nogo-functions | |
AUPQ639300A0 (en) | Method of enhancing or maintaining a relationship | |
AU2002252802A1 (en) | Method for identifying modulators of transcription | |
AU2002241725A1 (en) | Circulator and method for manufacture | |
AU2001286091A1 (en) | Methods for identifying modulators of protein interactions | |
AU2002228975A1 (en) | Method | |
AU2001235770A1 (en) | Method | |
AU2001269061A1 (en) | Transfection method |